Effects of protein-deficient nutrition during rat pregnancy and development on developmental hindlimb crossing due to methylmercury intoxication.
Pregnant rats were fed either a control (20% protein) or low (3.5%) protein diet during gestation and lactation. The pups were separated from their mothers on postnatal day 21, and were given the same diet as their corresponding mothers. The groups of pups from each diet group were treated on either postnatal day 21 or postnatal day 60 with 7.5 mg methylmercury chloride (MeHgCl) per kg b.w. once daily by gavage for 10 consecutive days, and the development of ataxia (hind-limb crossing) was monitored. The offspring from mothers on the protein-deficient diet were found to be more sensitive to MeHg-induced ataxia than those on the protein-sufficient diet. The former accumulated more mercury in different brain regions than the latter. The rates of protein synthesis in different brain regions of the offspring fed the protein-deficient diet were significantly reduced compared with the rates in those fed the protein-sufficient diet. However, MeHg treatment did not significantly modify the rates of such protein synthesis further in protein-deficient rats. Thus, a significantly much higher inhibition of the intrinsic rates of protein synthesis in different brain regions due to severe protein deficiency, as observed in this study, may be partly responsible for the increased susceptibility of developing rats fed a protein-deficient diet to MeHg-induced ataxia, or hindlimb crossing, although other factor(s) might also be involved.
Chakrabarti
S K
SK
Departement de médecine du travail et hygiene du milieu, Faculté de médecine, Université de Montréal, Quebec, Canada.
Bai
C
C
D000818:Animals; D001259:Ataxia / Q000139:chemically induced / Q000209:etiology*; D001835:Body Weight / Q000502:physiology; D001921:Brain / Q000378:metabolism; D004044:Dietary Proteins / Q000008:administration & dosage; D005260:Female; D006614:Hindlimb; D007774:Lactation; D008628:Mercury / Q000493:pharmacokinetics; D008767:Methylmercury Compounds / Q000493:pharmacokinetics / Q000633:toxicity*; D009419:Nerve Tissue Proteins / Q000096:biosynthesis; D011247:Pregnancy; D011248:Pregnancy Complications / Q000378:metabolism / Q000503:physiopathology; D011297:Prenatal Exposure Delayed Effects; D011502:Protein-Energy Malnutrition / Q000150:complications*; D051381:Rats; D017207:Rats, Sprague-Dawley
D004044:Dietary Proteins; D008767:Methylmercury Compounds; D009419:Nerve Tissue Proteins; D008628:Mercury; C004925:methylmercuric chloride